Tag: analysis

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee” or the “Corporation”) announces that its wholly owned subsidiary, Dundee Resources Limited, has acquired via a private placement 1,454,553 common shares of Bulgold Inc. (TSXV - ZLTO) (the “Issuer”) at the price of C$0.05 per share for aggregate consideration of C$72,727.65.

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.

The Australian legal cannabis market, valued at USD 123.9M in 2024, is projected to reach USD 540.6M by 2030, with a CAGR of 23.70%. Growth drivers include cannabis legalization, government initiatives, and new product launches. Market highlights: hemp dominates revenue, CBD leads the market, and industrial applications prevail. Explore comprehensive market insights, trends, and competitive strategies for informed decisions.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PepGen To Contact Him Directly To Discuss Their Options

The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.